Form 4: Fulgent Genetics President & COO Reports Stock Disposition for Tax Obligations

Fulgent Genetics, Inc.'s President and COO, Jian Xie, reported the disposition of 4,352 shares of common stock at $18.37 per share to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Jian Xie, President and COO of Fulgent Genetics, Inc. (FLGT), reported a transaction involving the company's common stock.
• On July 26, 2025, 4,352 shares of common stock were disposed of at a price of $18.37 per share.
• The disposition was made to satisfy tax withholding obligations that arose upon the vesting of certain restricted stock units.
• These restricted stock units were assumed pursuant to an Agreement and Plan of Merger dated November 7, 2022, and were originally reported on a Form 4 filed on November 9, 2022.
• Following this transaction, Jian Xie directly beneficially owns 367,144 shares of common stock.
• Additionally, 220,816 shares are indirectly beneficially owned through The Hsieh Family Dynasty Trust, dated January 27, 2010, where Mr. Xie serves on the investment committee and disclaims beneficial interest except for pecuniary interest.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction for tax withholding purposes, which is a neutral event and does not indicate positive or negative sentiment regarding the company's performance or outlook.

Future Outlook

No forward-looking statements or guidance are provided in this filing.

Industry Context

This filing reports a routine insider transaction common across all industries, where executives dispose of shares to cover tax liabilities arising from the vesting of equity awards. It does not provide specific insights into broader industry trends or competitive dynamics.

Related Party Transactions

• Indirect beneficial ownership of 220,816 common shares is held by The Hsieh Family Dynasty Trust, dated January 27, 2010. The reporting person, Mr. Xie, serves on the investment committee of this Trust and disclaims beneficial interest except for any pecuniary interest.

Stakeholder Impact

• Shareholders: The transaction is a routine insider disposition for tax purposes and is unlikely to have a significant direct impact on existing shareholders, as it does not reflect a change in management's confidence or strategic direction.

Key Dates

Recommendation

The Form 4 filing details a routine disposition of shares by an executive to cover tax obligations upon the vesting of restricted stock units. This type of transaction is a standard part of executive compensation and does not reflect a change in the executive's confidence in the company or its future prospects. Therefore, it provides no new information that would warrant a change in investment recommendation.

Keywords

Fulgent Genetics, FLGT, Jian Xie, Insider Transaction, Stock Disposition, Tax Withholding, Restricted Stock Units, Executive Compensation, Beneficial Ownership